BMC’s Yawkey building doors are now closed as an entrance as part of our ongoing efforts to enhance our campus and provide you with the best clinical care.

All patients and visitors on our main campus must enter our hospital via Shapiro, Menino, or Moakley buildings, where they will be greeted by team members at a new centralized check-in desk before continuing to the hospital. We are excited to welcome you and appreciate your patience as we improve our facilities.

The Scleroderma Clinic at Boston Medical Center is a multidisciplinary center that offers comprehensive care and cutting-edge research for patients with scleroderma, an autoimmune disease that causes the skin and internal organs to harden. The clinic is recognized internationally as a leader in scleroderma, and is the largest and oldest scleroderma program in New England, offering patients the highest level of expertise, experience, and innovation. Our mission is to improve your quality of life and health outcomes through state-of-the-art patient care and advanced therapeutic research. To do this, we provide the latest diagnostic and therapeutic measures available, including clinical trials and collaboration with specialists in cardiology, pulmonology, dermatology, gastroenterology, physical therapy, occupational therapy, orthopedics, urology, and others as needed. 

Contact Us

Our Team

Elizabeth S Klings, MD

Pulmonologist, Director of the Center for Excellence in Sickle Cell Disease, Director of the Pulmonary Hypertension Center

Clinical Trials

If you are interested in participating in clinical trials, please contact Kimberly Finch at 617-358-6785.

Research Overview

Boston Medical Center is a leading center for scleroderma research, offering the latest diagnostic and therapeutic measures for patients with this rare and complex disease. The Pulmonary and Rheumatology Departments, as well as other specialists, collaborate on scleroderma research, conducting clinical trials and translational studies to test new medications and diagnostic devices. Our AADC research center also works to understand the underlying mechanisms of scleroderma and fibrosis and find ways to prevent and reverse them. The research team also collaborates with other leading centers around the world and with the Scleroderma Clinical Trials Consortium and National Scleroderma Foundation, and maintains a valuable collection of clinical data and patient samples for research purposes. 

Residency and Fellowship Information

Boston Medical Center is affiliated with the Boston University Chobanian & Avedisian School of Medicine.

To learn about our academic and fellowship programs in rheumatology, please visit: